Avid Bioservices Total Revenue

Avid Bioservices (CDMO) currently reports a total revenue of $150M as of October 2024. That compares with $140M in the prior-year period — up 6.7% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Avid Bioservices's total revenue history and peer comparisons.

Avid Bioservices's total revenue increased from $140M to $150M — a 6.7% year-over-year increase (period ending October 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Avid Bioservices's total revenue of $150M is lower than the Healthcare sector average of $110B. That is roughly 99.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Avid Bioservices reported $150M in total revenue as of October 2024. That compares with $140M in the prior-year period — up 6.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $150M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Avid Bioservices, and consider following CDMO for alerts when major investors trade the stock.